)
)
Septerna Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Septerna Inc
Access all reports
Septerna Inc. is a biotechnology company focused on the discovery and development of innovative therapies targeting G protein-coupled receptors (GPCRs). The company leverages proprietary technology to design small molecule therapeutics aimed at addressing unmet medical needs across various disease areas. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Septerna Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Septerna Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Septerna Inc
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
SEPN
Country
🇺🇸 United States